Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Dietary fiber effects on breath VOCs in healthy adults

Official title: Characterization of Fiber-degrading Microbiota in Individuals Without Gastrointestinal Diseases

Run by Örebro University, Sweden · NCT07594600 · Data updated 2026-11-12

This study tests how a short course of high- versus low-fiber diets changes the volatile compounds in breath for healthy adults aged 18–65.

More Healthy Older Adults trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment20 (estimated)
SponsorÖrebro University, Sweden
Academic / other
Locations1 site (Örebro)
StatusRecruiting
StartedMay 25, 2026
Main results expectedNovember 2026
Study endsMarch 2027
Registry record updatedJune 4, 2026
Trial IDNCT07594600 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18–65 without gastrointestinal diseases or conditions that could affect gut physiology.

Probably not a fit

Individuals with recent antibiotic use, gastrointestinal surgery, or ongoing GI disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This crossover study compares two short-term dietary interventions (high-fiber and low-fiber diets) in healthy adults. Breath samples are collected at baseline and after each dietary period to characterize volatile organic compounds (VOCs) and identify patterns linked to fiber intake. The goal is to determine when VOCs peak after eating and whether a high-fiber diet shifts the breath profile toward fermentation-related metabolites. Results may inform sampling timing and deepen understanding of how fiber fermentation influences breath VOCs.

Why it matters

Potential benefit: If successful, the study could clarify breath biomarkers of fiber fermentation and improve methods for noninvasive dietary monitoring.

How similar studies have gone: Previous research in related areas has shown diet can alter breath VOCs, but this exact high- vs low-fiber, short-term crossover design is less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Signed informed consent obtained prior to any study-related procedures.
2. Willingness to refrain from regular consumption of prebiotic or probiotic products, as well as medications known to affect gastrointestinal function, for at least four weeks prior to the study visits.

Exclusion Criteria:

1. History of complicated gastrointestinal surgery.
2. Presence of a gastrointestinal diagnosis or any condition that, in the opinion of the principal investigator, may influence the study outcomes.
3. Current diagnosis of a psychiatric disorder.
4. Systemic use of antibiotics or steroid medications within the past 3 months.
5. Frequent use of NSAIDs (non-steroidal anti-inflammatory drugs) within the 2 months preceding the study visit.
6. Regular consumption of prebiotic or probiotic products within the past 4 weeks.
7. Alcohol or substance abuse.
8. Current smoking or use of nicotine pouches.
9. Frequent use of laxatives, antidiarrheal agents, or anticholinergic medications within the 12 weeks preceding the study visit.
10. Pregnancy or breastfeeding.
11. Respiratory disease or infection.

Where it's running

  • Örebro University
    Örebro, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.